Antonio Ceriello
Antonio Ceriello publishes mostly in Endocrinology, Diabetes and Metabolism, Molecular Biology and Cardiology and Cardiovascular Medicine, on topics such as Diabetes Treatment and Management, Diabetes Management and Research and Diabetes, Cardiovascular Risks, and Lipoproteins.
- World rank
- #493,756 of 7,710,434 ranked researchers
- Rank in Italy
- #13,774 of 242,206
- Works
- 51
- Citations
- 1.5k
- Citations per work
- 29.3
What does Antonio Ceriello research?
Antonio Ceriello's work is mostly in Medicine (68%), Biochemistry, Genetics and Molecular Biology (14%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3567.8%
- Medicine3567.8%
- Everything else917.9%
- Life Sciences714.3%
- 1Endocrinology, Diabetes and Metabolism47% of their works
- 2Molecular Biology10% of their works
- 3Cardiology and Cardiovascular Medicine10% of their works
- 4Nephrology7% of their works
- 5Genetics4% of their works
- 6Physiology4% of their works
Research topics
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Metabolism, Diabetes, and Cancer
- Chronic Kidney Disease and Diabetes
- Blood Pressure and Hypertension Studies
- Diabetes and associated disorders
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
Which keywords describe Antonio Ceriello's research?
The keywords of their largest research topics: Cardiovascular Disease, Glycemic Control, Insulin Therapy, Diabetes, Clinical Guidelines, Type 1 Diabetes, Cardiovascular Outcomes and Type 2 Diabetes.
- Hyperglycemia
- Genetics
- Hypertension
- Glomerular Filtration Rate
- Metformin
- Diabetes Mellitus
- Metabolic Syndrome
- Hypoglycemia
- Type 2 Diabetes
- Type 1 Diabetes
- Diabetes
- Glycemic Control
- Cardiovascular Disease
- Insulin Therapy
- Clinical Guidelines
- Cardiovascular Outcomes
- Continuous Glucose Monitoring
- Insulin Resistance
- Global Burden
- AMP-Activated Protein Kinase
- Chronic Kidney Disease
- Blood Pressure
- Autoimmunity
- Critical Care
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 24 words, with their numbers
- Cardiovascular Disease494 topics
- Glycemic Control423 topics
- Insulin Therapy423 topics
- Diabetes342 topics
- Clinical Guidelines272 topics
- Type 1 Diabetes242 topics
- Cardiovascular Outcomes201 topic
- Type 2 Diabetes201 topic
- Continuous Glucose Monitoring181 topic
- Hypoglycemia181 topic
- Insulin Resistance161 topic
- Metabolic Syndrome161 topic
- Global Burden152 topics
- Diabetes Mellitus112 topics
- AMP-Activated Protein Kinase91 topic
- Metformin91 topic
- Chronic Kidney Disease81 topic
- Glomerular Filtration Rate81 topic
- Blood Pressure71 topic
- Hypertension71 topic
- Autoimmunity61 topic
- Genetics61 topic
- Critical Care41 topic
- Hyperglycemia41 topic
Where does Antonio Ceriello work?
Antonio Ceriello's main affiliation in the publication record is MultiMedica, Italy.
How many publications and citations does Antonio Ceriello have?
OpenAlex counts 51 works and 1,493 citations for Antonio Ceriello, an h-index of 22, ranking #493,756 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Antonio Ceriello
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Antonio Ceriello. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.